Non-Hodgkin's Lymphoma

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Non-hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (IMMU-114)

Terminated
  • Non-hodgkin's Lymphoma
  • +5 more
  • Newark, Delaware
  • +4 more
Aug 12, 2021

Non-Hodgkin's Lymphoma Trial in United States (fludarabine and rituximab, fludarabine, rituximab, pixantrone)

Withdrawn
  • Non-Hodgkin's Lymphoma
  • fludarabine and rituximab
  • fludarabine, rituximab, pixantrone
  • Muscle Shoals, Alabama
  • +7 more
Oct 2, 2020

Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

Completed
  • Related Donors Donating PBSC to a Family Member
  • +7 more
  • Tampa, Florida
  • +11 more
Sep 3, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • Mobile, Alabama
  • +120 more
Dec 20, 2019

Solid Tumors, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (PLX51107)

Terminated
  • Solid Tumors
  • +3 more
  • New York, New York
  • +4 more
Dec 20, 2018

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Columbus (Velcade, Rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Columbus, Ohio
    Ohio State University Medical Center
Mar 7, 2018

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

Completed
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +127 more
Jan 8, 2018

Non-Hodgkin's Lymphoma Trial in Columbus (Clofarabine)

Completed
  • Non-Hodgkin's Lymphoma
  • Columbus, Ohio
    Ohio State University
Dec 4, 2017

Non-Hodgkin's Lymphoma Trial in Columbus (CHOP, Alemtuzumab, Plasma Samples)

Completed
  • Non-Hodgkin's Lymphoma
  • Columbus, Ohio
    Ohio State University
Jan 19, 2017

Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease Trial in United States

Completed
  • Lymphoblastic Leukemia, Acute, Childhood
  • +3 more
  • Los Angeles, California
  • +19 more
Nov 20, 2015

Non-Hodgkin's Lymphoma Trial in Worldwide (YM155, Rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • Columbus, Georgia
  • +18 more
Sep 29, 2015

Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • Los angeles, California
  • +70 more
Aug 15, 2014

Non-Hodgkin's Lymphoma Trial in Australia, Canada, United States (bendamustine and rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • bendamustine and rituximab
  • Anchorage, Alaska
  • +33 more
May 8, 2014

Acute Leukemia, Chronic Leukemia, Multiple Myeloma Trial in United States (AVN-944 capsules for oral administration)

Completed
  • Acute Leukemia
  • +5 more
  • AVN-944 capsules for oral administration
  • Tucson, Arizona
  • +4 more
Aug 2, 2011

Non-Hodgkin's Lymphoma Trial in United States (Id-KLH)

Unknown status
  • Non-Hodgkin's Lymphoma
  • Id-KLH
  • La Jolla, California
  • +14 more
Sep 29, 2009

Non-Hodgkin's Lymphoma Trial in United States (Xcellerated T Cells)

Unknown status
  • Non-Hodgkin's Lymphoma
  • Xcellerated T Cells
  • Greenbrae, California
  • +17 more
Jun 23, 2005